The skinny on diagnosing skin disease

Lichen sclerosus is an autoimmune skin disorder that occurs in more than 1 in 300 people. The disease, which presents with hardened inflamed bumps or patches of skin, most commonly in the genital area, can result in severe scarring, resulting in impaired sexual activity, and can also be complicated by malignancy, most commonly squamous cell carcinomas. There are no biological markers or diagnostic tests to adequately diagnose this common skin disorder, and it is often misdiagnosed as signs of abuse in young children and as lichen planus in adults. Previous work on lichen sclerosus has shown the presence of specific autoantigens to extracellular matrix protein 1 (ECM1), implicating its potential involvement in the disease. ECM1 is a protein present in the epidermis and dermis, and appears to be involved in epidermal differentiation and in protein-protein interactions within the skin. John McGrath and colleagues, from St. Thomas' Hospital in London, have now characterized the portions of EMC1 that are targeted by autoantibodies from the serum of lichen sclerosus patients. They find that patient's serum contains antibodies that detect many different portions of ECM1, but were able to identify a portion of this protein (amino acids 359 to 559) that is detected by autoantibodies in the serum of nearly all disease cases. From this, they developed a novel and highly sensitive ELISA system that provides a diagnostic marker for this disease, and also gives indication of the likely clinical severity. This study provides an essential new diagnostic tool for the detection of this often debilitating skin disease, but it also presents important information on the underlying pathogenicity of the disease, in terms of the development of multiple antibodies to ECM1, a phenomenon called "epitope spreading," which is frequently seen in other autoimmune skin disorders.


Contact: Laurie Goodman
Journal of Clinical Investigation

Page: 1

Related biology news :

1. Experts offer the skinny on search for healthy fat
2. Molecular imaging: diagnosing diseases before symptoms strike
3. Comprehensive set of vision genes discovered: Identification could help in diagnosing and treating blinding diseases
4. Blood test for diagnosing schizophrenia
5. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
6. Alzheimers disease is not accelerated aging
7. New molecular link key to cellular proteins involved in cancer progression, other diseases
8. Wildlife Conservation Society hosts public symposium on human-wildlife diseases
9. University of Alberta researcher looks for clues to mysterious disease
10. Study explores gene transfer to modify underlying course of Alzheimers disease
11. Experimental drug shown to block mutant protein causing blood disease

Post Your Comments:

(Date:7/26/2019)... ... July 25, 2019 , ... ... the first mixed reality headsets to include a new generation eye tracker with ... in Los Angeles, California (July 30 - August 1). SIGGRAPH attendees will ...
(Date:7/23/2019)... Conn. (PRWEB) , ... July 23, 2019 , ... ... that provides personalized, easy-to-understand, web-based genetic counseling, today announced that the company has ... related to MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The ...
(Date:7/23/2019)... ... July 23, 2019 , ... NanoFUSE is pleased ... strip indicated for spine and orthopedic use. Bioactive glass is a calcium phosphate ... been clinically-proven in orthopedics for over 30 years and now NanoFUSE Biologics has ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... August 06, 2019 , ... The ... the launch of a community project that will engage middle and early high ... project, entitled “A Youth-Led Citizen Science Network for Community Environmental Assessment.” Collaborative partners ...
(Date:7/19/2019)... (PRWEB) , ... July 18, 2019 , ... ... Instrumente) announced their investment to enlarge their current piezo motion facilities in Lederhose, ... offer 3 floors for multilayer piezo ceramic assembly production in addition to general ...
(Date:7/11/2019)... VEGAS (PRWEB) , ... July 11, 2019 , ... At ... R3 provided complimentary regenerative therapies to eight military Veterans under the R3 Heroes Program. ... being complimentary. , The R3 Heroes Program allow anyone to nominate a military Veteran, ...
(Date:6/18/2019)... N.J. (PRWEB) , ... June 17, 2019 , ... ... announced that they have entered into an agreement for production and manufacturing of ... for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for ...
Breaking Biology Technology:
Cached News: